Quartan malarial nephrotic syndrome.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000349:Africa; D000906:Antibodies / Q000032:analysis; D001485:Basement Membrane; D002196:Capillaries / Q000473:pathology; D002648:Child; D004487:Edema / Q000209:etiology; D004739:England; D005260:Female; D005921:Glomerulonephritis / Q000473:pathology; D006417:Hematuria / Q000209:etiology; D006801:Humans; D007019:Hypoproteinemia / Q000209:etiology; D007678:Kidney Glomerulus / Q000473:pathology; D008288:Malaria / Q000150:complications* / Q000276:immunology; D008297:Male; D009404:Nephrotic Syndrome / Q000150:complications / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D010965:Plasmodium malariae; D011507:Proteinuria / Q000209:etiology; D012709:Serum Albumin / Q000032:analysis
D000305:Adrenal Cortex Hormones; D000906:Antibodies; D012709:Serum Albumin